Cargando…

Treatment Options That Reduce the Duration of Sickle Cell Vaso-Occlusive Crises: A Systematic Review

Most patients with sickle cell disease (SCD) seek hospital care because of pain symptoms. While some patients opt to treat themselves at home, some prefer to seek treatment in a hospital setting. There are, however, some patients with more complicated effects of the disease who seek treatment so oft...

Descripción completa

Detalles Bibliográficos
Autores principales: Akindele, Adebisi O, Jalkh, Ana P, Eastmond, Aziza K, Shetty, Chaitra, Rizvi, Syed Muhammad Hannan Ali, Sharaf, Joudi, Williams, Kerry-Ann D, Tariq, Maha, Acharekar, Maitri V, Guerrero Saldivia, Sara Elena, Unnikrishnan, Sumedha N, Chavarria, Yeny Y, Balani, Prachi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510888/
https://www.ncbi.nlm.nih.gov/pubmed/36176876
http://dx.doi.org/10.7759/cureus.28337
_version_ 1784797541658787840
author Akindele, Adebisi O
Jalkh, Ana P
Eastmond, Aziza K
Shetty, Chaitra
Rizvi, Syed Muhammad Hannan Ali
Sharaf, Joudi
Williams, Kerry-Ann D
Tariq, Maha
Acharekar, Maitri V
Guerrero Saldivia, Sara Elena
Unnikrishnan, Sumedha N
Chavarria, Yeny Y
Balani, Prachi
author_facet Akindele, Adebisi O
Jalkh, Ana P
Eastmond, Aziza K
Shetty, Chaitra
Rizvi, Syed Muhammad Hannan Ali
Sharaf, Joudi
Williams, Kerry-Ann D
Tariq, Maha
Acharekar, Maitri V
Guerrero Saldivia, Sara Elena
Unnikrishnan, Sumedha N
Chavarria, Yeny Y
Balani, Prachi
author_sort Akindele, Adebisi O
collection PubMed
description Most patients with sickle cell disease (SCD) seek hospital care because of pain symptoms. While some patients opt to treat themselves at home, some prefer to seek treatment in a hospital setting. There are, however, some patients with more complicated effects of the disease who seek treatment so often that they have been termed “super-users.” This paper seeks to determine, across the board, the treatments available for vaso-occlusive crisis (VOC), the most common complication of SCD. Due to the frequency and unpredictable nature of VOC, it is no surprise that the lives of so many patients dealing with SCD are constantly disrupted by this complication. Treatments that reduce the frequency of VOC and the need for hospital admissions will help these patients find some semblance of balance in their quality of life.
format Online
Article
Text
id pubmed-9510888
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-95108882022-09-28 Treatment Options That Reduce the Duration of Sickle Cell Vaso-Occlusive Crises: A Systematic Review Akindele, Adebisi O Jalkh, Ana P Eastmond, Aziza K Shetty, Chaitra Rizvi, Syed Muhammad Hannan Ali Sharaf, Joudi Williams, Kerry-Ann D Tariq, Maha Acharekar, Maitri V Guerrero Saldivia, Sara Elena Unnikrishnan, Sumedha N Chavarria, Yeny Y Balani, Prachi Cureus Emergency Medicine Most patients with sickle cell disease (SCD) seek hospital care because of pain symptoms. While some patients opt to treat themselves at home, some prefer to seek treatment in a hospital setting. There are, however, some patients with more complicated effects of the disease who seek treatment so often that they have been termed “super-users.” This paper seeks to determine, across the board, the treatments available for vaso-occlusive crisis (VOC), the most common complication of SCD. Due to the frequency and unpredictable nature of VOC, it is no surprise that the lives of so many patients dealing with SCD are constantly disrupted by this complication. Treatments that reduce the frequency of VOC and the need for hospital admissions will help these patients find some semblance of balance in their quality of life. Cureus 2022-08-24 /pmc/articles/PMC9510888/ /pubmed/36176876 http://dx.doi.org/10.7759/cureus.28337 Text en Copyright © 2022, Akindele et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Emergency Medicine
Akindele, Adebisi O
Jalkh, Ana P
Eastmond, Aziza K
Shetty, Chaitra
Rizvi, Syed Muhammad Hannan Ali
Sharaf, Joudi
Williams, Kerry-Ann D
Tariq, Maha
Acharekar, Maitri V
Guerrero Saldivia, Sara Elena
Unnikrishnan, Sumedha N
Chavarria, Yeny Y
Balani, Prachi
Treatment Options That Reduce the Duration of Sickle Cell Vaso-Occlusive Crises: A Systematic Review
title Treatment Options That Reduce the Duration of Sickle Cell Vaso-Occlusive Crises: A Systematic Review
title_full Treatment Options That Reduce the Duration of Sickle Cell Vaso-Occlusive Crises: A Systematic Review
title_fullStr Treatment Options That Reduce the Duration of Sickle Cell Vaso-Occlusive Crises: A Systematic Review
title_full_unstemmed Treatment Options That Reduce the Duration of Sickle Cell Vaso-Occlusive Crises: A Systematic Review
title_short Treatment Options That Reduce the Duration of Sickle Cell Vaso-Occlusive Crises: A Systematic Review
title_sort treatment options that reduce the duration of sickle cell vaso-occlusive crises: a systematic review
topic Emergency Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510888/
https://www.ncbi.nlm.nih.gov/pubmed/36176876
http://dx.doi.org/10.7759/cureus.28337
work_keys_str_mv AT akindeleadebisio treatmentoptionsthatreducethedurationofsicklecellvasoocclusivecrisesasystematicreview
AT jalkhanap treatmentoptionsthatreducethedurationofsicklecellvasoocclusivecrisesasystematicreview
AT eastmondazizak treatmentoptionsthatreducethedurationofsicklecellvasoocclusivecrisesasystematicreview
AT shettychaitra treatmentoptionsthatreducethedurationofsicklecellvasoocclusivecrisesasystematicreview
AT rizvisyedmuhammadhannanali treatmentoptionsthatreducethedurationofsicklecellvasoocclusivecrisesasystematicreview
AT sharafjoudi treatmentoptionsthatreducethedurationofsicklecellvasoocclusivecrisesasystematicreview
AT williamskerryannd treatmentoptionsthatreducethedurationofsicklecellvasoocclusivecrisesasystematicreview
AT tariqmaha treatmentoptionsthatreducethedurationofsicklecellvasoocclusivecrisesasystematicreview
AT acharekarmaitriv treatmentoptionsthatreducethedurationofsicklecellvasoocclusivecrisesasystematicreview
AT guerrerosaldiviasaraelena treatmentoptionsthatreducethedurationofsicklecellvasoocclusivecrisesasystematicreview
AT unnikrishnansumedhan treatmentoptionsthatreducethedurationofsicklecellvasoocclusivecrisesasystematicreview
AT chavarriayenyy treatmentoptionsthatreducethedurationofsicklecellvasoocclusivecrisesasystematicreview
AT balaniprachi treatmentoptionsthatreducethedurationofsicklecellvasoocclusivecrisesasystematicreview